Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2020-07-12 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于公司首次公开发行前已发行股份上市流通的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the listing and circulation of shares of Shenzhen BGI Genomics Co., Ltd. before its initial public offering (IPO). It includes specific information about shareholding, lock-up commitments, shareholder names, share release dates, and compliance with regulatory requirements. The document references regulatory approvals and stock exchange rules, and it is issued by the sponsor institution as a formal opinion on share circulation post-IPO. This type of document is a regulatory compliance and verification report related to share circulation and lock-up release, which does not fit into categories like Annual Report, Earnings Release, or Capital Update. It is not a simple announcement or a proxy statement but a formal verification opinion. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory compliance documents that do not fit other categories. The document length (6020 characters) and content confirm it is a full report, not just an announcement or certification.
2020-07-12 Chinese
首次公开发行前已发行股份上市流通提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the lifting of share lock-up restrictions for certain shareholders before the company's initial public offering (IPO). It includes specifics about the number of shares becoming tradable, shareholder commitments, and compliance with regulatory requirements. The document references regulatory approvals and stock exchange rules but does not contain financial statements or performance data. It is not an annual or interim report, earnings release, or management discussion. Instead, it is a regulatory announcement about share circulation and shareholder commitments related to share lock-up release. This fits best under Regulatory Filings (RNS), as it is a compliance and disclosure document that does not fit other specific categories.
2020-07-12 Chinese
前次募集资金使用情况鉴证报告（2019年12月31日）
Audit Report / Information Classification · 95% confidence The document is titled as a "前次募集资金使用情况鉴证报告" which translates to "Verification Report on the Use of Previous Fundraising Proceeds." It includes detailed information about the use of funds raised in a prior issuance, including amounts raised, allocation, usage, and compliance with regulatory requirements. The report is prepared by an accounting firm (Ernst & Young Hua Ming) providing an attestation on the use of the funds. The document references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange regarding fundraising management and usage. It contains detailed financial data and analysis on the use of the proceeds, including tables showing amounts invested, project progress, and benefits realized. This type of document is a standalone audit or attestation report on fundraising proceeds usage, not a full annual or interim report, nor a simple announcement. It fits the definition of an Audit Report / Information (AR) as it is a standalone audit/verification report on a specific financial aspect (fundraising proceeds usage). The document length is over 10,000 characters and contains substantive financial data and analysis, so it is not a mere announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2019
2020-07-01 Chinese
2020年度创业板非公开发行A股股票方案论证分析报告
Capital/Financing Update Classification · 95% confidence The document is titled "深圳华大基因股份有限公司 2020 年度创业板非公开发行 A 股股票方案 论证分析报告" which translates to "Shenzhen BGI Genomics Co., Ltd. 2020 Non-public Issuance of A Shares Plan Demonstration and Analysis Report." The content discusses the background, purpose, legal compliance, pricing, and fairness of a non-public issuance of A shares (equity financing) by the company. It includes detailed analysis of the issuance plan, regulatory compliance, pricing methodology, and impact on shareholders. There is no indication that this is an earnings release, annual report, or other financial statement. Instead, it is a detailed capital/financing update related to a specific equity issuance. The document length is substantial (15,000 characters), and it contains substantive content about the financing plan rather than just an announcement or a brief summary. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-07-01 Chinese
关于召开2020年第四次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2020 fourth extraordinary general meeting of shareholders for Shenzhen BGI Genomics Co., Ltd. It includes information about the meeting date, agenda items, voting procedures, registration details, and attachments such as proxy forms and voting instructions. The content focuses on the announcement and procedural details for a shareholders' meeting rather than the meeting materials or results themselves. There is no indication that this is a presentation, transcript, or report of the meeting outcomes. Therefore, this document fits the category of a Proxy Solicitation & Information Statement (PSI), which is used to inform shareholders about meeting details and solicit their votes.
2020-07-01 Chinese
关于2020年度创业板非公开发行A股股票摊薄即期回报、采取填补措施及相关主体承诺的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a non-public issuance of A shares by Shenzhen BGI Genomics Co., Ltd. It discusses the dilution of immediate returns, measures to compensate for this dilution, and commitments by related parties. The document includes financial assumptions, impact analysis on key financial indicators, risk warnings, project investment plans, governance measures, and commitments by controlling shareholders and management. It references regulatory requirements and approvals from the China Securities Regulatory Commission and Shenzhen Stock Exchange. The content focuses on capital raising activities, the impact on shareholders, and related governance and commitment disclosures. It is not a full annual or interim financial report, nor an earnings release or audit report. It is not a simple announcement of a report publication but a substantive disclosure about a capital financing event and related shareholder impact and measures. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2020-07-01 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.